• 대한화학회지
• /
• 제34권5호
• /
• pp.490-497
• /
• 1990

1,4-dibora-2-cyclohexene 고리화합물 8을 합성하기 위한 두 가지 방법이 개발되었다. 방법 i)은 1,2-bis(dichloroaluminyl)ethane을 출발물질로 하는데 이 물질은 AlCl$_2$ 부분을 BCl$_2$로 치환시켜준다. 1,2-bis(dichloroaluminyl)ethane에 결합된 염소를 BI$_3$로 교환시켜 대응되는 요오드 화합물을 얻고 이 화합물을 alkynes와 반응시켜 헤테로고리화합물 8a, b를 많이 얻었다. 방법 ii)는 B$_2$Cl$_4$를 alkynes에 부가시켜 얻어지는 염소화합물에 BI$_3$를 치환시켜 bis(diiodoboryl)ethane유도체를 얻고 이 화합물에 alkynes와 산화환원반응을 하여줌으로 8c, d를 얻는다. 요오드 유도체인 8a는 pyridine 부가물인 9a를 생성하고 또 ether와 반응하여 ethoxy 유도체인 8e를 생성시킨다. 요오드 유도체의 dimethyl amino 치환제가 8f이다. 8a-d와 AlMe$_3$를 반응시켜 대응되는 methyl유도체인 8g-j를 얻고 이들 화합물은 THF속에서 칼륨과 반응시켜 불안정한 라디칼 음이온이 생성되고 여기서 ESR 결과가 측정된다. 8g-j의 전기화학적인 실험이 비가역적인 환원반응으로 나타났다. 8g-j화합물은 (C$_5$H$_5$)CO(C$_2$H$_4$)$_2$와 반응하여 중간체인 16개 VE(valence electron)를 갖는 착물 (C$_5$H$_5$)Co(8)이 얻어지는데 이 화합물은 다시 C-H 활성화에 의해 대응되는 붉은색의 1,4-diboracyclohexene 착물 10을 생성하게 된다. 착물 10h와 10j의 X-ray 구조가 결정되었다.

• Toxicological Research
• /
• 제14권3호
• /
• pp.293-300
• /
• 1998

Previous studies have shown that the heterocycles including thiazoles are efficacious in inducing phase phase II metabolizing enzyme as well as certain cytochrome P450s and that the inductin of these matabolizing enzymes by the heterocyclic agents is highly associated with their hepatotoxicity. In the present study, the effects of benzylisothiazole (BIT), which has a isothiazole moiety, on the expression of microsomal epoxide hydrolase (mEH), major glutathione S-transerases and cytochrome P450s were studied in the rat liver in association with its hepatotoxicity. Treatment of rats with BIT(1.17 mmol/kg, 1~3d) resulted in substantial increases in the mEH. rGSTA2, rGSTA2, rGSTM1 and rGSTM2 mRNA levels, whereas rGSTA3 and rGSTA5 mRNA levels were increased to much lesser extents. A time-course study showed that the mRNA levels of mEH and rGSTs were greater at 24hr after treatment than those after 3 days of consecutive treatment. Relative changes in mEH and rGST mRNA levels were consistent with those in the proteins, as assessed by Western immunoblot analysis. Hepatic cytochrom P450 levels were monitored after BIT treatment under the assumption that metabolic activation of BIT may affect expression of the enzymes in conjunction with hepatotoxicity. Immunoblot analysis revealed that cytochrome P450 2B1/2 were 3-to 4-fold induced in rats teatd with BIT(1.17 mmol/kg/day.3days), whereas P450 1A2, 2C11 and 3A1/2 levels were decreased to 20~30% of those in unteatd rats. P450 2E1 was only slightly decreased by BIT. Thus, the levels of several cytochrome P450s were suppressed by BIT treatment. Rats treated with BIT at the dose of 1.17mmol/kg for 3 days exhibited extensive multifocal nodular necrosis with moderate to extensive diffuse liver cell degeneration. No notable toxicity was observed in the kidney. These results showed that BIT induces mEH and rGSTs in the liver with increases in the mRNA levels, whereas the agent significantly decreased major cytochrome P450s. The changes in the detoxifying enzymes might be associated with the necrotic liver after consecutive treatment.